Christopher Foley
About Christopher Foley
Christopher Foley is the Associate Director at Bristol Myers Squibb in San Diego, California, with extensive experience in biomedical research and commercialization, focusing on orphan indications and oncology.
Current Role at Bristol Myers Squibb
Christopher Foley currently holds the position of Associate Director at Bristol Myers Squibb. He is based in San Diego, California, United States. His role involves overseeing various projects and strategic initiatives within the company, with a focus on research and development in the biomedical field.
Previous Roles and Experience at Bristol Myers Squibb
Before becoming an Associate Director, Christopher Foley served as Senior Manager of Research Alliance at Bristol Myers Squibb from 2020 to 2022. In this position, he was responsible for coordinating and managing research alliances and collaborations aimed at advancing biomedical research and commercialization.
Professional Experience at Allterum Therapeutics
Christopher Foley was the Director of Operations at Allterum Therapeutics from 2019 to 2020. In this role, he was involved in overseeing the operational aspects of the company, focusing on the development and commercialization of therapeutic solutions.
Positions Held at Fannin Innovation Studio
Christopher Foley had a series of roles at Fannin Innovation Studio, including Principal (2019-2020), Associate Principal (2018-2019), Entrepreneurship Fellow (2017-2018), and Intern (2016-2017). During his time at Fannin, he gained extensive experience in biomedical innovation, regulatory strategy, and business development.
Education and Academic Background
Christopher Foley earned a PhD in Cell/Cellular and Molecular Biology from Baylor College of Medicine, where he studied from 2012 to 2017. He also holds a BS in Biochemistry and Cell Biology from UC San Diego, obtained between 2007 and 2010. Additionally, he has an International Baccalaureate Diploma from Springbrook High School.
Specialization in Orphan Indications and Oncology
Christopher Foley specializes in the design and management of preclinical experiments with a focus on orphan indications and oncology. His expertise includes the development of regulatory and business strategies to support biomedical commercialization.